Finance

Lists
000623:SHE
Jilin Aodong Pharmaceutical Group Co Ltd
17,10 CN¥
-0,29%
(-0,050) 1D
16-окт., 15:04:09 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 000623...
Open
17,22 CN¥
High
17,38 CN¥
Low
17,00 CN¥
Mkt. cap
20,81 млд
Avg. vol.
9,08 млн
Volume
10,80 млн
P/E ratio
6,34
52-wk high
22,08 CN¥
52-wk low
16,36 CN¥
EPS
2,70 CN¥
Shares outstanding
1,20 млд
No. of employees
5 миң
Open
17,22 CN¥
High
17,38 CN¥
Low
17,00 CN¥
Mkt. cap
20,81 млд
Avg. vol.
9,08 млн
Volume
10,80 млн
P/E ratio
6,34
52-wk high
22,08 CN¥
52-wk low
16,36 CN¥
EPS
2,70 CN¥
Shares outstanding
1,20 млд
No. of employees
5 миң
News stories
From web sources and news partners
Profile
Jilin Aodong Medicine Industry Group Company Limited is a state-owned enterprise in Dunhua, Jilin, China. It involves in the manufacture and sale of Chinese patent drugs and pharmaceutical packaging products, and the collection of traffic tolls and the road engineering construction business. It was established in 1993 and listed on the Shenzhen Stock Exchange in 1996. Wikipedia
About Jilin Aodong Pharmaceutical Group Co Ltd
CEO-
Employees5,05 миң
Founded1993-ж., 20-мар.
Headquarters-
SectorPharmaceutical industry
Websitejlaod.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
513,94 млн
694,88 млн
514,09 млн
516,91 млн
Cost of goods sold
277,23 млн
401,66 млн
265,19 млн
285,23 млн
Cost of revenue
277,23 млн
401,66 млн
265,19 млн
285,23 млн
Research and development expenses
20,32 млн
50,31 млн
14,36 млн
14,41 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
217,18 млн
375,32 млн
194,13 млн
204,97 млн
Operating expense
213,20 млн
462,78 млн
225,97 млн
230,21 млн
Total operating expenses
490,43 млн
864,44 млн
491,16 млн
515,45 млн
Operating income
23,51 млн
-169,57 млн
22,94 млн
1,46 млн
Other non operating income
8,50 млн
-11,31 млн
-653,65 миң
1,59 млн
EBT including unusual items
1,02 млд
76,89 млн
865,54 млн
1,14 млд
EBT excluding unusual items
881,21 млн
310,73 млн
905,90 млн
1,31 млд
Income tax expense
46,89 млн
-29,05 млн
446,06 миң
-39,10 млн
Effective tax rate
4,58%
-37,77%
0,05%
-3,42%
Other operating expenses
-17,06 млн
38,39 млн
10,48 млн
10,49 млн
Net income
978,96 млн
134,74 млн
866,00 млн
1,18 млд
Net profit margin
190,48%
19,39%
168,45%
229,06%
Earnings per share
-
-
-
-
Interest and investment income
865,41 млн
507,32 млн
898,86 млн
1,31 млд
Interest expense
-16,21 млн
-15,71 млн
-15,25 млн
-6,62 млн
Net interest expenses
849,20 млн
491,61 млн
883,61 млн
1,31 млд
Depreciation and amortization charges
-
-
-
-
EBITDA
74,98 млн
-121,80 млн
70,71 млн
44,84 млн
Gain or loss from assets sale
127,66 миң
-1,32 млн
-
4,80 млн
AI content may include mistakes. Learn more
Google колдонмолору